)
Polaryx Therapeutics (PLYX) investor relations material
Polaryx Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for September 10, 2026, at 9:00 a.m. Eastern Time, to be held virtually.
Shareholders are encouraged to review proxy materials online and may request paper or email copies at no charge.
Voting matters and shareholder proposals
Election of Class I Directors with nominees Alex Yang, J.D., LL.M, and Mitchel Berger, M.D.
Ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board recommends voting "FOR ALL NOMINEES" and "FOR" the auditor ratification proposal.
Board of directors and corporate governance
Board is presenting two nominees for election as Class I Directors.
- PLX-200 targets multiple rare pediatric LSDs with strong preclinical data and a flexible Phase 2 trial.PLYX
Company presentation28 Jul 2026 - Shareholders will vote on director elections and auditor ratification, with strong governance and oversight.PLYX
Proxy filing28 Jul 2026 - PLX-200 targets multiple rare pediatric LSDs with strong preclinical data and flexible clinical strategy.PLYX
Corporate presentation15 May 2026 - Q1 2026 net loss fell to $2.5M; cash runway extends through Q3 2026, further funding required.PLYX
Q1 202615 May 2026 - Net loss improved to $9.0M in 2025, but cash only funds operations through Q3 2026.PLYX
Q4 202524 Mar 2026 - PLX-200 advances in a flexible Phase 2 trial for rare pediatric LSDs, targeting broad market impact.PLYX
Corporate presentation16 Mar 2026 - Pre-revenue biotech with a lead LSD therapy pursues Nasdaq direct listing, faces funding needs.PLYX
Registration Filing3 Feb 2026 - Direct listing on Nasdaq for a rare disease biotech with no revenue and high clinical risk.PLYX
Registration Filing3 Feb 2026 - Direct listing of 47.3M shares for rare disease biotech with no proceeds, high risk, and key trial ahead.PLYX
Registration Filing3 Feb 2026
Next Polaryx Therapeutics earnings date
Next Polaryx Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)